Delivery Order SPE2DR25D1053-SPE2DR26FU862
- Not listed
- The Defense Logistics Agency awarded a $2,279.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Nucynta 100 mg tablets (100-count units) on December 5, 2025, with an ultimate completion date of December 8, 2025. This is a non-set-aside, competitively awarded contract with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger prime indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,850.28 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 100 mg tablets (60-count packages) on November 20, 2025, with completion scheduled for November 21, 2025. This firm fixed-price, non-set-aside contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,312.52 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 50 mg tablets (60 count) on December 2, 2025, with a completion date of December 3, 2025. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) valued at $2,650.80. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is set to complete by October 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a $2,334.68 delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Nucynta ER 200 mg tablets (60-count units). This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $1 billion through December 2026. The award utilized firm fixed pricing with no set-aside designation, reflecting competitive procurement through open competition....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Nucynta 100 mg tablets (100-count units) under a firm fixed-price contract valued at $1,908.20. This is a non-set-aside competitive award issued as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999.99 billion and extending through December 2026. The...
- The Defense Logistics Agency awarded a $1,837.60 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Nucynta 50 mg tablets (100-count packages). This firm fixed-price contract, which is not set-aside and competitively awarded, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is the company's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) with a ceiling value of $1,425.14. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is set to be completed by November 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of NUCYNTA ER 100 mg tablets (60-count units) valued at $2,850.28 with firm fixed pricing. The contract is non-set-aside and competitively awarded, with an ultimate completion date of December 16, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $2,729.17 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 150 mg tablets (60-count units) on June 20, 2025, with an ultimate completion date of June 23, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FU862Delivery Order
The Defense Logistics Agency awarded a $2,137.68 delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units). This firm fixed-price, non-set-aside contract is scheduled for completion by December 19, 2025, with performance at the vendor's Conshohocken, Pennsylvania location. The order represents a child action under AmerisourceBergen's larger pharmaceutical supply relationship with DLA. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military healthcare programs globally. The current delivery order for Nucynta ER exemplifies the company's role in supplying pain management pharmaceuticals to federal medical procurement needs, serving customers including the Defense Health Agency and U.S. Coast Guard through a flexible contracting structure designed to support military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 12/17/25 |